Caris Life Sciences (CAI) Total Current Liabilities (2024 - 2026)

Caris Life Sciences' Total Current Liabilities history runs 3 years deep, the most recent figure standing at $143.9 million for Q1 2026.

• In Q1 2026, Total Current Liabilities changed N/A year-over-year to $143.9 million; the TTM figure through Mar 2026 stood at $143.9 million (changed N/A YoY), while the FY2025 annual figure was $127.1 million, down 23.14% from the prior year.
• Total Current Liabilities was $143.9 million for Q1 2026 at Caris Life Sciences, up from $127.1 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $165.4 million in Q4 2024 to a low of $86.0 million in Q3 2025.
• Historically, Total Current Liabilities has averaged $122.5 million across 3 years, with a median of $127.1 million in 2025.
• Biggest YoY gain for Total Current Liabilities was 23.14% in 2025; the steepest drop was 23.14% in 2025.
• A 3-year view of Total Current Liabilities shows it stood at $165.4 million in 2024, then decreased by 23.14% to $127.1 million in 2025, then advanced by 13.17% to $143.9 million in 2026.
• The last three Total Current Liabilities figures came in at $143.9 million (Q1 2026), $127.1 million (Q4 2025), and $86.0 million (Q3 2025), per Business Quant data.